WORLD CLASS STATE OF THE ART FACILITY
Ziska Pharma has established a world class, state-of-the-art and dedicated Oncology & Biotech manufacturing unit high-containment (OEB-4) processing and testing facility under consultancy and support by Rob Walker & Associates, A UK based GMP consultancy firm.
WIDE RANGE OF COMPLEX GENERICS & DRUG DELEVERY BASED FORMULATIONS
This facility manufactures the most advanced targeted therapies, biotech products, monoclonal antibodies & immunotherapies including oral solids, pre-filled syringes, liquid vials and lyophilized products for both local and international markets. Our major production and quality control machineries are from world-reputed sources like MAR- Italy, Labotrade-Spain, Last Technology- Italy, Biorad- USA, Arctiko-Denmark, Tofflon-China etc..
OEB-4 CONTAINMENT COMPLIANT
All production machines for solid and sterile operates under OEB-4 Containment compliant with 21 CFR Part 11. OEB-4 Containment is strictly followed at every critical stage of operations of tablets, liquid injections, and lyophilized products to ensure the safety of people and to avoid cross-contamination of oncology and biotech products.
MB Lab
Pre Filled Syringe
Pre Filled Syringe
Vial Filling Machine
PREMIUM QUALITY RAW MATERIALS
All of the products of oncology & biotech are manufactured with USDMF, COS grade raw materials and axillary items from world-renowned sources from China, Europe and Latin America through rigorous quality control and manufacturing processes which ensures an extended clinical outcome for the patients.
NATION WIDE PATIENT SERVICE POINTS
Ziska Oncology & Biotech has 18 patient service points across the country which ensures cold chain maintained (2-8°C) robust medicine delivery system starting from manufacturing to patients’ hands. In these service points, highly trained professionals not only serve the medicine to the patients but also provides fast and free home delivery for the patients’ convenience.
